PAREXEL International (PRXL) Provides Update On Expected Third Quarter Fiscal 2005 Financial Results
10/19/2005 5:13:04 PM
More...
|
PAREXEL Consulting To Validate First cGMP Biopharmaceutical Contract Manufacturing Facility In South Korea
10/19/2005 5:12:15 PM
More...
|
PAREXEL International (PRXL) Acquires QdotPharma, a Phase I/IIa Clinical Pharmacology Unit
10/19/2005 5:11:57 PM
More...
|
PAREXEL International (PRXL) Reports First Quarter Fiscal 2005 Financial Results
10/19/2005 5:11:52 PM
More...
|
PAREXEL International (PRXL) Reports Third Quarter Fiscal 2005 Financial Results
10/19/2005 5:11:02 PM
More...
|
PAREXEL International (PRXL) Acquires Clinical Pharmacology Units 3ClinicalResearch (PRXL); $12 Million
10/19/2005 5:10:59 PM
More...
|
PAREXEL International (PRXL) Appoints Professor Herman Scholtz As Vice President And Worldwide Head Of Clinical Pharmacology
10/19/2005 5:10:02 PM
More...
|
PAREXEL International (PRXL): New Text First To Profile U.S. Biologics Product Regulation Following CBER/CDER Consolidation
10/19/2005 5:09:55 PM
More...
|
PAREXEL International (PRXL) To Present At UBS Warburg Global Healthcare Services Conference
10/19/2005 5:09:47 PM
More...
|
PAREXEL International (PRXL) Announces Fourth Quarter Restructuring Charge; Relocation Or Elimination Of Approximately 150 Positions
10/19/2005 5:09:43 PM
More...
|
|